Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25253
Title: The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival.
Austin Authors: Fedele, Pasquale L;Liao, Yang;Gong, Jia-Nan;Yao, Yuan;van Delft, Mark F;Low, Michael S Y;Tai, Lin;Herold, Marco J;Jackson, Jacob T;Teh, Charis E;Tan, Tania;O'Reilly, Lorraine A;Tellier, Julie;Grigoriadis, George;Huang, David C S;Shi, Wei;Nutt, Stephen L;Willis, Simon N
Affiliation: School of Computing and Information Systems, The University of Melbourne, Parkville, VIC, 3010, Australia
The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia
Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australia
Haematology Department, Monash Health, Clayton, VIC, 3168, Australia
School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
School of Medicine, Tsinghua University, Beijing, China
Olivia Newton-John Cancer Research Institute
School of Cancer Medicine, La Trobe University, Heidelberg, VIC, 3084, Australia
Issue Date: Jul-2021
Date: 2020-11-04
Publication information: Leukemia 2021; 35(7): 2114-2118
URI: https://ahro.austin.org.au/austinjspui/handle/1/25253
DOI: 10.1038/s41375-020-01078-0
ORCID: 0000-0003-3999-8309
0000-0002-6396-2739
0000-0002-3101-4873
0000-0002-0020-6637
0000-0001-7330-1275
Journal: Leukemia
PubMed URL: 33149265
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

40
checked on Jan 7, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.